+91-8591768159  |    info@heyanhealth.com   Book Free Demo
Call Us WhatsApp Book Demo

Pioneering Cardiac Diagnostics
for Every Indian

We are Heyan Health Solutions Pvt Ltd — a BIRAC-funded medical device company on a mission to make clinical-grade ECG accessible to every Indian, regardless of geography, infrastructure, or technical expertise.

BIRAC Grant ₹50 Lakh Indian Patent — July 2025 ACC · JACC · ESC Published
Our Purpose

What Drives Us Every Day

Our Mission

"Make 12-lead ECG accessible to every Indian, regardless of geography or infrastructure."

Cardiac disease does not discriminate by postcode. A patient in a remote district deserves the same diagnostic quality as a patient in a metropolitan hospital. DILasa makes that possible — today, at scale.

  • Zero infrastructure requirement
  • Operable by any healthcare worker
  • Designed for India's diverse population

Our Vision

"A cardiac-emergency-free India through intelligent, accessible, and affordable diagnostics."

We envision a future where every sudden cardiac event is detected before it becomes fatal — where technology bridges the gap between rural patients and world-class cardiac care.

  • AI-powered early detection at the point of care
  • Cardiology expertise delivered via the cloud
  • Affordable diagnostics for Bharat, not just India
Our Journey

From a Rural Ward to a Patented Innovation

The story of DILasa began not in a lab, but beside a hospital bed — where one cardiologist saw a patient die waiting for an ECG that never came.

2019

The Idea Is Born

Dr. Gurunath Parale, a cardiologist with over three decades of clinical experience, witnesses a rural patient die from a preventable cardiac event — the only obstacle being access to a timely ECG. He conceives a wearable vest that eliminates technician dependency and brings 12-lead ECG to the bedside in seconds.

2020

Prototype Development Begins

Shriram Kulkarni brings his 20+ years of embedded systems expertise to the project. A core engineering team assembles to design the first hardware prototype of the DILasa vest — a garment with 12 pre-positioned dry-contact electrodes and an onboard Bluetooth data acquisition module.

2021

First Clinical Trials

DILasa undergoes its first structured clinical trials under Dr. Parale's supervision. Initial data from prospective testing confirms diagnostic equivalence to conventional 12-lead ECG placement across a diverse patient cohort. The results validate the core concept and set the stage for international peer review.

2022

ESC Congress Presentation

DILasa is presented at the European Society of Cardiology (ESC) Congress 2022 — among the most prestigious cardiology forums in the world. The presentation receives international recognition for innovation in point-of-care cardiac diagnostics, marking the first of three consecutive ESC Congress presentations (2022, 2023, 2024).

2023

BIRAC Grant — ₹50 Lakh Awarded

Heyan Health Solutions is awarded a ₹50 Lakh grant by BIRAC (Biotechnology Industry Research Assistance Council, Govt. of India) under its BIG scheme. This milestone validates the technology's national significance and funds the next phase of product development, clinical expansion, and regulatory submissions.

2024

ACC / JACC Publication

Clinical trial data is published in the Journal of the American College of Cardiology (JACC) and presented at ACC sessions — confirming DILasa's 12-lead accuracy, operator-independence, and clinical utility in diverse settings. This peer-reviewed publication is a cornerstone of the global evidence base supporting DILasa's commercial deployment.

2025

Indian Patent Granted

Milestone

On July 15, 2025, Heyan Health Solutions is granted an Indian Patent for the DILasa wearable ECG vest technology — protecting the pre-positioned electrode garment design, the signal acquisition methodology, and the AI-assisted interpretation system. This patent cements DILasa's position as India's first and only patented wearable 12-lead ECG solution.

The Team

Expertise Across Cardiology, Engineering & Business

Heyan Health Solutions combines deep clinical expertise with cutting-edge medical device engineering — a rare combination that makes DILasa both clinically rigorous and practically deployable.

Prashant Sadavarte
Prashant Sadavarte
CEO & Co-Founder

Serial healthcare entrepreneur with deep experience in MedTech business strategy, market development, and health system partnerships. Leads commercial strategy, investor relations, and go-to-market execution for DILasa across India and emerging markets.

HealthTech Strategy Business Development MedDevice Commercialisation
Shriram Kulkarni
Shriram Kulkarni
CTO & Co-Founder

20+ years of hands-on experience in embedded systems, firmware architecture, and medical device engineering. The principal architect behind DILasa's hardware platform, electrode signal processing chain, and Bluetooth data acquisition system. Holds expertise in IEC 60601 medical device standards compliance.

Embedded Systems Medical Hardware 20+ Yrs Experience
Dr. Gurunath Parale
Dr. Gurunath Parale
Founder & Chief Cardiologist

MD & DM Cardiology. 32 years of clinical practice spanning rural health camps, district hospitals, and tertiary cardiac centres. The clinical visionary behind DILasa — designed every aspect of the device's ECG acquisition protocol and led all peer-reviewed validation studies presented at ACC, JACC, and ESC.

MD / DM Cardiology 32 Yrs Clinical Practice Clinical Trials Lead
Prof. Dr. Nachiket Thakur
Prof. Dr. Nachiket Thakur
Clinical Advisor

Renowned professor, cardiologist, and clinical researcher with a distinguished academic and hospital career. Provides strategic guidance on clinical study design, evidence generation, regulatory pathway planning (CDSCO), and positioning DILasa within India's healthcare ecosystem.

Clinical Research Regulatory Strategy Academic Cardiology
Company Details

Heyan Health Solutions Pvt Ltd

Company Information
Company Name Heyan Health Solutions Pvt Ltd
Registered Office C-3, Neelkanth Sadan CHS,
Sector-10, Khanda Colony,
New Panvel (W), Maharashtra
Works / R&D 1608/14, Shobha Nagar,
Civil Lines, Solapur,
Maharashtra – 413003
Email info@heyanhealth.com
Phone +91-8591768159

Recognition & Certifications

BIRAC Grant — ₹50 Lakh

Awarded by Biotechnology Industry Research Assistance Council (BIRAC), Government of India, under the BIG scheme. Validates DILasa as a nationally significant medical innovation.

Indian Patent — Granted July 15, 2025

Indian Patent Office protection for the DILasa wearable ECG vest — covering the electrode vest design, signal acquisition methodology, and AI-assisted interpretation system.

Peer-Reviewed Publications

Published in ACC & JACC. Presented at ESC Congress 2022, 2023, and 2024. Featured in the Indian Heart Journal. Clinically validated across multiple patient cohorts and geographic settings.

32+ yrs
Clinical Cardiology Expertise
4
Global Cardiology Bodies

ACC · JACC · ESC · Indian Heart Journal

₹50L
BIRAC Grant Funding
1
Indian Patent Granted 2025

India's first wearable 12-lead ECG patent

Partner With Us

Partner with India's Most Validated
Wearable ECG Company

Whether you are a clinician, a healthcare institution, a corporate wellness program, or an investor — we have a partnership model for you. Let's build cardiac-safe India together.

Book a Demo Contact Us View Clinical Evidence